Toggle light / dark theme

Apple, Boeing, MIT, and more partner with Pentagon to improve flexible electronics

A consortium of top tech companies, laboratories, and universities is partnering with the Department of Defense to improve the manufacturing of flexible electronics, which could one day end up in aircraft, health monitors, military tools, or consumer electronics like wearables. The department is awarding the consortium, known as the FlexTech Alliance, $75 million over five years, with other sources, including universities, non-profits, and state and local governments, contributing an additional $96 million.

The consortium is composed of well over 100 organizations, with key partners including Apple, Boeing, GE, GM, Lockheed Martin, Motorola Mobility, and Qualcomm, among many others. Partnering universities include Cornell, Harvard, Stanford, NYU, and MIT, also among many others.

Funds will be distributed to FlexTech members through a bidding process, with field experts from these organizations applying to tackle specific problems. Timelines will be set for each of these, though there don’t appear to be specific goals just yet.

Read more

Gene That Controls the Internal Clock Discovered

The circadian rhythm is a subject of many studies, yet it remains a mystery in many ways. While scientists have identified many of the cell proteins involved in circadian rhythm and several genes that contribute to a healthy rhythm, the ‘master clock’ gene remained elusive. However, a recent chronobiology study on rats indicates that the Zfhx3, or Zinc Finger Homeobox 3, gene may be the master gene that dictates this important biological rhythm.

Read more

Can We Reprogram Cancer Cells Back To Normal?

Most cancer-busting strategies focus on removing cancerous cells. While this approach has proved extremely effective on many patients, most treatments have unpleasant side effects and there are many strains which prove extremely challenging to remove. An alternative model to this is to alter instead of remove — fixing cancerous behaviour by ‘reprogramming’ cells that go rogue; essentially swiss finishing school for cellular miscreants. A study published in Nature Cell Biology now provides hope that this tactic could in fact work in many cancers.

Researchers from Mayo Clinic’s Florida campus have found that adhesion proteins, which act like a glue sticking cells together, actually interact with a cell’s ‘microprocessor’. This processor creates molecules called miRNAs, which regulate multiple genes and essentially activate or de-activate different behavioural programs (like commands in computer programming). When healthy cells bump into a neighbour and begin to glue together, these adhesion proteins normally influence both cells — tuning down growth pathways. In cancer, the lab found this adhesion is perturbed; de-regulating miRNA production and enabling rampant growth. When scientists corrected these miRNA levels, the growth was arrested.

“The study brings together two so-far unrelated research fields — cell-to-cell adhesion and miRNA biology — to resolve a long-standing problem about the role of adhesion proteins in cell behavior that was baffling scientists. Most significantly, it uncovers a new strategy for cancer therapy”

Read more

Rise Of The Organoids: Miniature Human Brain Most Complete To Date

As regenerative medicine expands, our ability to engineer organs is growing with it. Researchers can now grow a number of so called ‘organoids’ — mini-organs which can teach us more about developmental biology and enable vastly improved testing. In the latest addition to the bunch, a team from Ohio State University has successfully engineered the most complete model yet of a human brain, with a similar maturity to a 5 week old fetus.

Containing 99% of the genes present in the human fetal brain, and about the size of an eraser, the organoid was developed from transformed adult human skin. This method could allow more ethical and precise clinical trials, both speeding up and enabling more rigorous, personalized testing. As animal testing frequently fails to predict varied human responses, these organoid models offer an alternative approach which could revolutionize clinical trial methodology.

“It not only looks like the developing brain, its diverse cell types express nearly all genes like a brain. We’ve struggled for a long time trying to solve complex brain disease problems that cause tremendous pain and suffering. The power of this brain model bodes very well for human health because it gives us better and more relevant options to test and develop therapeutics other than rodents.”

Read more

The Longevity Reporter: The Weekly Newsletter on Aging (22nd August, 2015)

Checkout the latest Longevity Reporter Newsletter (22nd August, 2015), covering this week’s top news in health, aging, longevity.

This week: An Entire Nervous System Captured On Film; 10 Enduring Health Myths, Debunked By Science; Peto’s Paradox: Why Don’t Larger Animals Get Cancer More Often?; Antioxidants: Separating Myth From Reality; And more.

Read more

This narcolepsy ‘smart drug’ makes ordinary people smarter

A medication called modafinil is commonly used to treat people who experience narcolepsy, but it’s suspected that the vast majority of those who use the drug are taking it for another purpose that isn’t medically authorised: as a general cognitive enhancer for tasks such as studying or meeting a deadline.

Now a comprehensive review of the medication has looked at this ‘off licence’ use of the drug by healthy, non-sleep-deprived subjects to determine whether modafinil is safe – and to confirm whether the belief that it acts as a general-purpose ‘smart drug’ is grounded in reality.

According to researchers from the University of Oxford in the UK and Harvard Medical School in the US, modafinil delivers on both counts, constituting what’s thought to be the first safe smart drug that can provide demonstrable cognitive and concentration benefits. Brainpower in a pill, in other words.

Read more

Antioxidants: Separating Myth From Reality

Ever since the free radical theory of aging was conceived in the 1950s, antioxidants have been a buzzword in health — saturating the cosmetic industry and contributing to a smoothie blending, supplement popping boom.


Ever since the free radical theory of aging was conceived in the 1950s, antioxidants have been a buzz word in health — saturating the cosmetic industry and contributing to a smoothie blending, supplement popping boom. While antioxidants can certainly play an essential role in health, there is growing evidence that additional supplementation has limited benefit and can actually be harmful in some cases.

Aging has yet to be ascribed to one, singular cause and the free radical theory has struggled to prove itself. While in some organisms reducing oxidative stress can prove beneficial and increasing mitochondria targeted catalase (an important antioxidant enzyme) production in mice showed a modest increase in lifespan, when important enzymes were knocked out in C. elegans (a model organism) there was curiously no reduction and reducing expression of various antioxidant mechanisms in mice also failed to reduce lifespan. While a certain amount of vitamins and antioxidant intake is necessary, as many are co-factors in essential reactions, it seems that aside from nutritional value there is little consensus regarding additional benefits.

Read more

10 Enduring Health Myths, Debunked By Science

Everything makes you fat! Gluten-free food is the key to eternal youth! You need to poop once per day or you’ll die! You’ll find tons of equally ridiculous health claims around the internet, and some of them are widely believed. Today we’re taking a look at 10 common myths and uncovering the truth.

While we’ve learned a lot about health issues here at Lifehacker over the years, we can’t claim expertise on any particular subject. To help us get to the root of these myths, we solicited the help of three experts: Dr Carly Stewart (medical expert at Money Crashers), Andy Bellatti (Las Vegas-based registered dietitian), and Dr Spencer Nadolsky (medical editor at Examine.com). They all offer a unique perspective on each myth but mostly came to the same conclusions: we have a lot of silly misinformation out there about our health.

Read more

11 Companies Leading the 3D Bioprinting Space

Undoubtedly one of the most exciting areas within the 3D printing space is that of bioprinting. Using layer-by-layer fabrication methods, a number of companies are in the process of pushing forward a new paradigm shift within the medical implant, transplantation, and surgical spaces. While the media has mainly focused on Organovo, the company behind the world’s first 3D printable liver tissue, there are actually several other companies involved in this incredible space. Here are 3DPrint.com we thought it would be helpful to underline just a handful of those companies that may be about to change medicine as we know it.

Organovo The company, headquartered in San Diego, California, has been at the forefront of 3D bioprinting research for some time now. Not only are they currently bringing revenues in by providing pharmaceutical companies with their aa3exVive3D™ Liver Tissue for drug toxicity testing, but they have partnered with major companies in the health space including L’Oréal and Merck, and are planning on introducing their exVive3D™ Kidney Tissue product by next year. With an ultimate goal of 3D printing patches made of human tissue for failing organs, and eventually entire organs for transplantation, Organovo certainly has their work cut out for them.

Read more